These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 9444954)

  • 1. Alternative splicing of fibroblast growth factor receptor 2 (FGF-R2) in human prostate cancer.
    Carstens RP; Eaton JV; Krigman HR; Walther PJ; Garcia-Blanco MA
    Oncogene; 1997 Dec; 15(25):3059-65. PubMed ID: 9444954
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alterations in expression of basic fibroblast growth factor (FGF) 2 and its receptor FGFR-1 in human prostate cancer.
    Giri D; Ropiquet F; Ittmann M
    Clin Cancer Res; 1999 May; 5(5):1063-71. PubMed ID: 10353739
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vivo progression of LAPC-9 and LNCaP prostate cancer models to androgen independence is associated with increased expression of insulin-like growth factor I (IGF-I) and IGF-I receptor (IGF-IR).
    Nickerson T; Chang F; Lorimer D; Smeekens SP; Sawyers CL; Pollak M
    Cancer Res; 2001 Aug; 61(16):6276-80. PubMed ID: 11507082
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Androgen receptor expression induces FGF2, FGF-binding protein production, and FGF2 release in prostate carcinoma cells: role of FGF2 in growth, survival, and androgen receptor down-modulation.
    Rosini P; Bonaccorsi L; Baldi E; Chiasserini C; Forti G; De Chiara G; Lucibello M; Mongiat M; Iozzo RV; Garaci E; Cozzolino F; Torcia MG
    Prostate; 2002 Dec; 53(4):310-21. PubMed ID: 12430142
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evidence that androgen-independent stromal growth factor signals promote androgen-insensitive prostate cancer cell growth in vivo.
    Ishii K; Imamura T; Iguchi K; Arase S; Yoshio Y; Arima K; Hirano K; Sugimura Y
    Endocr Relat Cancer; 2009 Jun; 16(2):415-28. PubMed ID: 19293288
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Down-regulation of (IIIb) and (IIIc) isoforms of fibroblast growth factor receptor 2 (FGFR2) is associated with malignant progression in human prostate.
    Naimi B; Latil A; Fournier G; Mangin P; Cussenot O; Berthon P
    Prostate; 2002 Aug; 52(3):245-52. PubMed ID: 12111699
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alternative splicing of fibroblast growth factor receptors in human prostate cancer.
    Kwabi-Addo B; Ropiquet F; Giri D; Ittmann M
    Prostate; 2001 Feb; 46(2):163-72. PubMed ID: 11170144
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An intronic sequence element mediates both activation and repression of rat fibroblast growth factor receptor 2 pre-mRNA splicing.
    Carstens RP; McKeehan WL; Garcia-Blanco MA
    Mol Cell Biol; 1998 Apr; 18(4):2205-17. PubMed ID: 9528792
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exon III splicing switch of fibroblast growth factor (FGF) receptor-2 and -3 can be induced by FGF-1 or FGF-2.
    Scotet E; Houssaint E
    Oncogene; 1998 Jul; 17(1):67-76. PubMed ID: 9671315
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhanced invasion and tumor growth of fibroblast growth factor 8b-overexpressing MCF-7 human breast cancer cells.
    Ruohola JK; Viitanen TP; Valve EM; Seppänen JA; Loponen NT; Keskitalo JJ; Lakkakorpi PT; Härkönen PL
    Cancer Res; 2001 May; 61(10):4229-37. PubMed ID: 11358849
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Studies on the expression of fibroblast growth factors and fibroblast growth factor receptors in human prostate cancer].
    Takahashi H
    Nihon Hinyokika Gakkai Zasshi; 1998 Oct; 89(10):836-45. PubMed ID: 9844400
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Potentiation of the antiangiogenic ability of linomide by androgen ablation involves down-regulation of vascular endothelial growth factor in human androgen-responsive prostatic cancers.
    Joseph IB; Isaacs JT
    Cancer Res; 1997 Mar; 57(6):1054-7. PubMed ID: 9067270
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stromal cell heterogeneity in fibroblast growth factor-mediated stromal-epithelial cell cross-talk in premalignant prostate tumors.
    Wu X; Jin C; Wang F; Yu C; McKeehan WL
    Cancer Res; 2003 Aug; 63(16):4936-44. PubMed ID: 12941818
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High frequency of fibroblast growth factor (FGF) 8 expression in clinical prostate cancers and breast tissues, immunohistochemically demonstrated by a newly established neutralizing monoclonal antibody against FGF 8.
    Tanaka A; Furuya A; Yamasaki M; Hanai N; Kuriki K; Kamiakito T; Kobayashi Y; Yoshida H; Koike M; Fukayama M
    Cancer Res; 1998 May; 58(10):2053-6. PubMed ID: 9605740
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of a soluble KGF receptor cDNA from human corneal and breast epithelial cells.
    Liu JJ; Shay JW; Wilson SE
    Invest Ophthalmol Vis Sci; 1998 Dec; 39(13):2584-93. PubMed ID: 9856768
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Imaging alternative splicing in living cells.
    Wagner EJ; Baines A; Albrecht T; Brazas RM; Garcia-Blanco MA
    Methods Mol Biol; 2004; 257():29-46. PubMed ID: 14769994
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Melatonin and prostate cancer cell proliferation: interplay with castration, epidermal growth factor, and androgen sensitivity.
    Siu SW; Lau KW; Tam PC; Shiu SY
    Prostate; 2002 Jul; 52(2):106-22. PubMed ID: 12111702
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NE-10 neuroendocrine cancer promotes the LNCaP xenograft growth in castrated mice.
    Jin RJ; Wang Y; Masumori N; Ishii K; Tsukamoto T; Shappell SB; Hayward SW; Kasper S; Matusik RJ
    Cancer Res; 2004 Aug; 64(15):5489-95. PubMed ID: 15289359
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acceleration of human prostate cancer growth in vivo by factors produced by prostate and bone fibroblasts.
    Gleave M; Hsieh JT; Gao CA; von Eschenbach AC; Chung LW
    Cancer Res; 1991 Jul; 51(14):3753-61. PubMed ID: 1712249
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Common and specific determinants for fibroblast growth factors in the ectodomain of the receptor kinase complex.
    Wang F; Lu W; McKeehan K; Mohamedali K; Gabriel JL; Kan M; McKeehan WL
    Biochemistry; 1999 Jan; 38(1):160-71. PubMed ID: 9890894
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.